Aplio i900 vs Reveal LINQ

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by Medtronic

AI Verdict

The Aplio i900 is a premium cardiovascular ultrasound system designed for real-time diagnostic imaging and structural/functional assessment of the heart. In contrast, the Reveal LINQ is an implantable cardiac monitor focused on long-term, continuous ECG recording and AI-powered detection of cardiac arrhythmias. While both leverage AI in cardiology, they address distinct diagnostic needs and employ fundamentally different technologies and deployment models.

Choose Aplio i900 if…

Choose the Aplio i900 if your clinical practice requires immediate, high-fidelity cardiovascular imaging for comprehensive diagnostic assessment and procedural guidance. This system is ideal for detailed structural heart analysis, advanced functional quantification, and real-time visualization of complex cardiac conditions in an acute or outpatient setting.

View Aplio i900 →

Choose Reveal LINQ if…

Choose the Reveal LINQ if you need a long-term, continuous cardiac monitoring solution for patients with infrequent or unexplained symptoms suggestive of arrhythmias. This implantable device is best suited for diagnosing elusive conditions like cryptogenic stroke, unexplained syncope, or paroxysmal atrial fibrillation that may not be captured by conventional, short-term monitoring methods.

View Reveal LINQ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aplio i900 Reveal LINQ
Pricing Varies Unknown
Deployment Mobile, compact diagnostic ultrasound system The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Aplio i900

Tool A, the Aplio i900, emphasizes 'Intuitive Ergonomics' and 'Touch-control Screens' for sonographers, directly addressing the daily hands-on interaction with a complex imaging system. While Tool B, Reveal LINQ, offers ease of implantation and remote monitoring via an app, Tool A's focus on streamlining the immediate user interface for its primary operator provides a stronger claim for traditional usability in its context. Reviews highlight its intuitive interface, customizable panels, and ergonomic design for sonographers, reducing physical strain and improving workflow.

Clinical Value

Reveal LINQ

Both tools offer significant clinical value, but Tool B, Reveal LINQ, addresses a critical and often challenging clinical gap: the long-term, accurate detection of intermittent cardiac arrhythmias. Its continuous monitoring for up to three years and AI algorithms for reduced false alerts directly lead to diagnoses for conditions like cryptogenic stroke and unexplained syncope, which are often missed by traditional methods. Numerous studies demonstrate its effectiveness in diagnosing atrial fibrillation in cryptogenic stroke patients, leading to changes in patient management and improved outcomes.

Pricing & Value

Reveal LINQ

Both products have non-transparent pricing, making a direct cost comparison impossible. However, in terms of 'value,' Reveal LINQ (Tool B) has more documented evidence and discussion around its cost-effectiveness in preventing adverse events like stroke by enabling early diagnosis of arrhythmias. Studies show that early detection can prevent recurrent strokes, leading to significant healthcare savings and improved patient outcomes, with incremental cost-effectiveness ratios well below established willingness-to-pay thresholds.

Enterprise Readiness

Reveal LINQ

Both are FDA cleared and HIPAA compliant, indicating foundational enterprise readiness. However, Tool B, Reveal LINQ, leverages a more extensive and mature distributed system with its implantable device, bedside patient monitor, mobile app for clinicians, and the established CareLinku2122 network for remote data management. Medtronic's long-standing infrastructure for managing a large volume of remote patient data demonstrates a robust and scalable enterprise solution for continuous monitoring and integration with EMRs.

Innovation

Reveal LINQ

Both tools showcase significant innovation. Tool A (Aplio i900) advances ultrasound imaging with AI-powered enhancements and advanced 4D capabilities. However, Tool B (Reveal LINQ) demonstrates a more disruptive innovation by combining extreme device miniaturization ('world's smallest insertable cardiac monitor') with extended battery life for continuous monitoring and AI algorithms that specifically reduce false alerts, directly addressing a critical challenge in long-term remote patient monitoring.

Support & Docs

Tie

Both Canon Medical Systems and Medtronic are leading global medical device manufacturers with extensive reputations for providing comprehensive support and documentation. Both companies offer technical service, clinical applications training, online resources, and dedicated customer support centers. Without specific comparative metrics on the quality or responsiveness of their support, it is not possible to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aplio i900 Reveal LINQ
Product Name Aplio i900 Reveal LINQ
Company Canon Medical Systems Corporation Medtronic
Description Summary A premium cardiovascular diagnostic ultrasound system featuring advanced 4D imaging, AI-powered image enhancement, and automated analysis tools for precise and efficient cardiac diagnostics. A tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias.
Key AI Feature/Algorithm AI-powered image enhancement, 3rd Harmonic Imaging (3-HI) with Deep Learning AI, Automated Analysis & Measurement Tools AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause)
Primary Clinical Application Precise and efficient cardiac diagnostics (cardiovascular imaging) Detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope (continuous ECG monitoring)
Unique Physical Characteristic/Form Factor Console Ultrasound System World's smallest insertable cardiac monitor (1.2 mL)

Videos

Demos, reviews, and walkthroughs featuring Aplio i900 and Reveal LINQ.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Aplio i900 is a premium cardiovascular diagnostic ultrasound system designed for advanced 4D imaging and automated analysis of cardiac structure and function. In contrast, the Reveal LINQ is an implantable cardiac monitor that continuously records ECG for up to three years to detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.
The Aplio i900 utilizes AI for image enhancement, automated analysis tools for measurements like EF, GLS, MPI, and 3D Wall Motion Tracking, and Deep Learning AI for 3rd Harmonic Imaging. The Reveal LINQ employs AccuRhythmu2122 AI algorithms specifically to accurately detect and diagnose cardiac arrhythmias and reduce false alerts related to AF and pauses.
The Aplio i900 is used for real-time, point-in-time diagnostic imaging sessions to assess cardiovascular health. The Reveal LINQ offers continuous ECG monitoring for an extended period, capable of recording data for up to three years after a minimally invasive insertion.
Both the Aplio i900 and Reveal LINQ are FDA-cleared and designed to comply with HIPAA regulations for handling protected health information (PHI). For the Aplio i900, a Business Associate Agreement (BAA) is not applicable as it is a medical device adhering to medical device regulations for data handling, while for Reveal LINQ, a BAA is implied by HIPAA compliance for medical devices handling PHI, with Medtronic emphasizing patient data protection.
The Aplio i900's key differentiators include advanced 4D imaging capabilities such as 4D TEE and MVA, along with features like SMI Angio for superb micro-vascular imaging. The Reveal LINQ stands out as the world's smallest insertable cardiac monitor, offering continuous ECG recording for extended periods and being MRI Conditional (1.5T and 3T) with no post-insertion waiting.
AI Tool Finder
AI-powered search. Results may not be comprehensive.